MC38-OVA BioVector?小鼠結(jié)腸癌穩(wěn)轉(zhuǎn)卵清蛋白細(xì)胞株Mouse Colon Adenocarcinoma cell line
- 價(jià) 格:¥998960
- 貨 號(hào):BioVector? MC38-OVA
- 產(chǎn) 地:北京
- BioVector NTCC典型培養(yǎng)物保藏中心
- 聯(lián)系人:Dr.Xu, Biovector NTCC Inc.
電話:400-800-2947 工作微信:1843439339 (QQ同號(hào))
手機(jī):18901268599
地址:北京
- 已注冊(cè)
BioVector? MC38-OVA cell line, a cornerstone model in cancer immunotherapy research used to study T-cell responses against a defined "foreign" antigen.
細(xì)胞名稱: MC38-OVA (或 MC38-OT-I/OT-II)
物種: 小鼠 (Mus musculus)
品系背景: C57BL/6
細(xì)胞類型: 結(jié)腸癌 (Colon Adenocarcinoma)
衍生自: 親本 MC38 細(xì)胞(來源于 C57BL/6 小鼠誘導(dǎo)的結(jié)腸腺癌)。
生物安全等級(jí): 1 (若涉及重組病毒轉(zhuǎn)導(dǎo),建議在 BSL-2 下操作)
遺傳修飾: 通過穩(wěn)定轉(zhuǎn)導(dǎo)/轉(zhuǎn)染技術(shù),使親本 MC38 細(xì)胞持續(xù)表達(dá)卵清蛋白 (Ovalbumin, OVA)。
模型用途: OVA 作為一種強(qiáng)效的模型新抗原 (Model Neoantigen),使其能被表達(dá)相應(yīng) TCR 的 T 細(xì)胞(如 OT-I 對(duì)應(yīng) CD8+ 或 OT-II 對(duì)應(yīng) CD4+)特異性識(shí)別。
應(yīng)用領(lǐng)域:
癌癥疫苗研發(fā)與驗(yàn)證。
過繼性 T 細(xì)胞療法 (ACT) 的效力評(píng)估。
免疫檢查點(diǎn)抑制劑 (ICI) 的藥效評(píng)價(jià)。
形態(tài)學(xué): 類上皮細(xì)胞,貼壁生長(zhǎng)。
培養(yǎng)基: DMEM 或 RPMI 1640 + 10% FBS + 1% P/S。
篩選壓力: 需添加 G418 (Geneticin) 或其他抗生素(取決于載體構(gòu)建)以維持 OVA 的穩(wěn)定表達(dá)。
培養(yǎng)條件: 37 °C, 5% CO?。
倍增時(shí)間: 約 18-24 小時(shí)。
冷凍保存: 90% FBS + 10% DMSO。

Cell Line Datasheet - English Version
Cell Line Name: MC38-OVA (also known as MC38-OT-I/OT-II)
Species: Mouse (Mus musculus)
Strain Background: C57BL/6
Cell Type: Colon Adenocarcinoma
Origin: Derivative of the parental MC38 line (a colon adenocarcinoma induced in C57BL/6 mice).
Biosafety Level: 1
Modification: Parental MC38 cells stably engineered to constitutively express the Ovalbumin (OVA) protein.
Mechanism: OVA acts as a potent surrogate tumor-associated antigen. It allows researchers to monitor specific T-cell responses using OT-I (CD8+ specific) or OT-II (CD4+ specific) T-cells.
Key Applications:
Validation of cancer vaccines.
Efficacy testing for Adoptive Cell Transfer (ACT).
In vivo syngeneic tumor models for Immunotherapy (e.g., anti-PD-1/anti-CTLA-4).
Morphology: Epithelial-like, adherent monolayer.
Culture Medium: DMEM or RPMI 1640 supplemented with 10% FBS and 1% Pen-Strep.
Selection Pressure: Requires maintenance with G418 (Geneticin) or similar selection markers to ensure stable OVA expression.
Incubation: 37 °C with 5% CO?.
Doubling Time: Approximately 18–24 hours.
Storage/Freezing: 90% FBS + 10% DMSO.

Technical Tip:
Because MC38-OVA is a syngeneic model for C57BL/6 mice, it is highly sensitive to the animal's immune status. Always verify OVA expression via flow cytometry or ELISA periodically, as transgene silencing can occur over many passages.Supplier生產(chǎn)廠家:
BioVector NTCC質(zhì)粒載體菌種細(xì)胞蛋白抗體基因保藏中心
BioVector NTCC Inc.
TEL: 400-800-2947
E-mail: [email protected]
工作微信/QQ同號(hào): 1843439339
您正在向 biovector.net 發(fā)送關(guān)于產(chǎn)品 MC38-OVA BioVector?小鼠結(jié)腸癌穩(wěn)轉(zhuǎn)卵清蛋白細(xì)胞株Mouse Colon Adenocarcinoma cell line 的詢問
- 公告/新聞




